Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Critical Analysis of Innovative Marketing Practices for Optimization in Selected Pharmaceutical Industry A THESIS Submitted for the Award of Ph.D. degree of PACIFIC ACADEMY OF HIGHER EDUCATION AND RESEARCH UNIVERSITY in the Faculty of Management Studies By Ruchi Sharma Under the Supervision of Prof. Ashok Kumar Jetawat FACULTY OF MANAGEMENT STUDIES PAHER UNIVERSITY UDAIPUR (Raj) – 313001 2014 1 Innovative Marketing Practices for Pharmaceutical Industries Pharmaceutical Industry is regulated by the production, distribution, selling and the marketing of the products or services which directly or indirectly includes medical, diagnostic and healthcare. It is regulated by economical, political and administrative authority to manage at all levels. So, the industry is governed by both the public and private sector. Therefore innovation is done in various pharma stakeholder and is needed in chronic and acute therapeutic segment. 2 Indian Pharmaceutical Industry • The Indian Pharmaceutical industry is divided in the organized and unorganized segments with more than 10,000 manufacturers. • It manufactures 23% bulk drugs that are active pharmaceutical ingredient and 77% formulations. • Institutional clients include government hospitals, Indian defense service and private hospital so the scope of strategies is not limited to private companies but has been also done in the public pharmaceutical sectors. • Challenges which needs to be met are dual disease burden, lack of infrastructure and manpower. 3 Objectives To study the comparative analysis of innovative practices of pharmaceutical company. To study the marketing strategy of the pharma companies that reduces the cost and effectively helps in managing the resources. To study and critically analyze the optimum techniques used by pharma organization. To study and find the issues, trends, future potential and suggestions. 4 Development in Public Healthcare • The Government has launched the National Rural Health Mission in 2005 to provide healthcare services to people and has increased the budget on healthcare to 2-3 per cent of GDP from 0.9 per cent of GDP in 2012. • Practices like setting feasible and Good Laboratory Practices, Biological Laboratories in Public-Private Partnership Mode are being planned by the government. • Besides this Government has initiated various PPP projects like Yashaswini Scheme, introduction of mobile health services in Tamil Nadu etc. 5 Development in Private Sector • In private sector, too there has been vast improvement done to provide the customer that is the patient with affordable, accessible and economical quality services to rural and urban masses. • Few actions have also been taken like training and educating the healthcare staff which include nurses, physician and related person. • Interventions like encouraging and extending CSR in cross functional formats are exchange programs, short stay certifications in areas like hospital administration, quality controls, specialized nursing care like intensive care and operation theatre. 6 Healthcare Industry Breakup Percentage of Various Sectors 15% Hospital Pharma 10% 50% Diagnostic Insurance and Medical equipment 25% 7 Research Design • Our research was exploratory in nature. Both quantitative and qualitative research was conducted. • Analysis of responses of physician and medical representative was a part of qualitative research which helped in collecting quantitative data so structured questionnaire was prepared to collect primary information. • The data were collected from both primary and secondary sources. During our primary research, two questionnaires were prepared i.e. appendix 5 and appendix 6. 8 Sampling Procedure and Size A convenient sample of two different groups was selected from Udaipur, Jaipur and NCR region as follows: Sample Size Medical Representative 369 Physician 100 The Sample Size of Physician is small due to few limitations. 9 Medical Representative's Profile Criteria Number 0-30 70 30-40 82 40-50 127 More than 50 90 Total 369 Male 277 Female 92 Total 369 B.A. 70 B. Com 82 B. Pharma 127 MBA 90 Total 369 Bhiwadi 70 Gurgaon 82 Udaipur 127 Jaipur 90 Total 369 Age Group Gender Group Qualification Geographical Area 10 Physician Profile Criteria Number 0-30 12 30-40 28 40-50 35 More than 50 25 Total 100 Male 60 Female 40 Total 100 Gurgaon 60 Udaipur 40 Total 100 Age Group Gender Group Geographical Area 11 Respondent Sample Profile of Medical Rep. Name of the Pharmaceutical Company Respondent BIOCON 86 PFIZER 98 IDPL 87 CIPLA 98 Total 369 12 Respondent Sample Profile of Physician Name of the Hospital Respondent FORTIS 20 MEDANTA 15 MAA GAYATRI 15 OTHERS 50 Total 100 13 Percentage of Total Responses Received from Pharma Industry 14 Percentage of Total Responses Received from Hospitals 15 Contributions of Individual Factors for Pharmaceutical Marketing 16 Contributions of Individual Factors for Pharmaceutical Marketing 17 Marks of Different Ranks Different Ranks Weightage Marks Rank 4 Strongly Agree 4 Rank 3 Agree 3 Rank 2 Disagree 2 Rank 1 S. Disagree 1 18 List of Individual Factors for Pharmaceutical Marketing : S. No. List of Individual Factors Total Score 1 Promotional Measures 330 2 Unethical Standard 327 3 Use of Technology 323 4 Fastest Growing Different Marketing Strategy Non Conventional Methods 319 7 Medical Ethics 259 8 MNC as Challenge 222 5 6 308 263 19 Chi Square Test for Awareness Level of Medical Rep. S. No. Hypothesis Result @ 5% level Ho 1 Awareness of promotional tools in pharmaceutical marketing is independent of gender Rejected Ho 2 Level of implementation of pharmaceutical marketing in private sector is independent of qualification Accepted Ho 3 Level of positive attitude towards innovation in private pharmaceutical sector is independent of age Accepted Ho 4 Ho 5 Ho 6 Ho 7 Level of positive attitude towards innovation in public pharmaceutical sector is independent of gender Level of awareness of promotional strategy mitigating corruption in pharmaceutical sector is independent of geographical area. Level of employee improvement in performance towards private pharmaceutical sector is independent of geographical area. Level of employee improvement in performance towards public pharmaceutical sector is independent of age . Accepted Accepted Accepted Rejected 20 Chi Square Test for Awareness Level of Physician S. No. Hypothesis Result @ 5% level Ho 8 Ho 9 Extent of agree level that India’s pharmaceutical industry is one of the fastest growing segments of the Indian economy is independent of gender. Level of marketing strategy of the pharmaceutical industry should be different from the marketing strategy in other industrial segments is independent of age. Accepted Accepted Ho 10 Level of awareness of pharmaceutical companies resort to promotional measures for selling their products is independent of age. Accepted Ho 11 Unethical standards exist in the promotion of pharmaceutical products in India is independent of gender. Accepted Ho 12 Entry of multinationals is a major challenge to the domestic players in the pharmaceutical market and are they ready to face the challenges of the foreign players is independent of area. Accepted Ho 13 Medical ethics as a major factor in the new distribution channel of marketing is independent of area. Accepted Ho 14 Non-conventional marketing methods are effective methods of pharmaceutical marketing in the present ages independent of area. Accepted Ho 15 Technology utilization and innovative distribution channels will help in marketing of pharmaceutical products in India is independent of gender. Rejected 21 Findings • Various domestic companies are competing with the foreign pharmaceutical firms. • Pharmaceutical marketing is taught from grass root level to all stakesholders so it shows uniformity in there implementation level. • Males were more aware about the promotional strategies than females. • Price approval mechanism takes 6-8 weeks. • People suggests that the public awareness should be enhanced. 22 Related Issues • Intense competition leads to unethical practices. • Lack of knowledge affects the strategies. • Varying customer perception leads to huge deviations. • High attrition rate of the sales personnel occur. • Cost affects the production and marketing strategy. • Time affects business value at medical representative level. 23 Conclusion • We analyzed the performance of various pharmaceutical companies working in few regions of Rajasthan and NCR on the basis of three aspects viz. marketing, human resource and technology. • Lack of general awareness among people regarding the healthcare services. Very few people are aware of the services provided by pharmaceutical firms. Thus, lack of marketing measures makes the efforts inefficient. • Various stakesholders are equally responsible for drug promotion. Therefore proper regulations help in lowering cost and providing the masses with best medications. 24 Future Potential & Suggestive Framework • Rational use of medicine can be done by pharmaceutical firms. • Marketing of drugs should be done by providing the physician with informative ideas about all drugs related to product. • Proper control on promotion is required and planning to improve its system so that all the documents can be registered and be returned within time and thereby saving the time. • Access to information by every stakesholder can play very important role in processing, marketing and prescribing drugs. 25 Future Potential & Suggestive Framework • It is important to find the key stakesholders which will help in better communication and can bring consistency in their services thereby reducing loss and dissatisfaction among people. • The internal, external and interactive dimensions should be considered by the pharmaceutical firms. • Companies can create differentiation by use of technology and innovations. Senior manager should be more friendly with the employees. • Market should be analyzed so proper use of ICT is required. So Pharmaceutical community should create online community so as to get right feedback. 26 Thank you! 27